Replay available

Opko Health, Inc. (OPK) Q2 2026 Earnings Call

Opko Health, Inc. (NASDAQ: OPK) Q2 2026 earnings conference call, held 2026-07-27. Replay captured from the company's public earnings webcast.

Mon, July 27, 2026 at 4:30 PMendedReplay
Opko Health, Inc. (OPK) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Vivian Cervantes

Alliance Advisors, Investor Relations

Dr. Philip Frost

Chairman and Chief Executive Officer

Dr. Elias Zerhouni

Vice Chairman and President

Adam Logal

Chief Financial Officer

Dr. Gary Nabel

Executive

Edward Tenthoff

Analyst, Piper Sandler

Kevin DeGeter

Analyst, Ladenburg Thalmann

Yale Jin

Analyst, Laidlaw & Company

Michael Petusky

Analyst, Barrington Research

Replay transcript excerpt

Good day and welcome to the Opco Health second quarter 2026 Business Highlights and Financial Results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touchtone phone. And to withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Ms. Vivian Cervantes of Investor Relations. Please go ahead, ma'am. Vivian Cervantes Thank you, Operator. Good afternoon, everyone. This is Vivian Cervantes with Alliance Advisors IR. Thank you all for joining us on today's call to discuss Opco Health's financial results for the second quarter 2026. I'd like to remind you that any statements made during this call by management other than statements of historical fact will be considered forward-looking and as such are subject to risks and uncertainties that could materially affect the company's results. Those forward-looking statements include without limitation the various risks described in the company's SEC filings, including the annual report on Form 10-K for the year ended December 31st, 2025. Furthermore, this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, July 27, 2026. Except as required by law, OPCO undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this call. Regarding the format of today's call, Dr. Philip Frost, Chairman and Chief Executive Officer, will provide opening remarks. Dr. Elias Zerhouni, Vice C...

More from Opko Health, Inc.